SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-03-003810
Filing Date
2003-11-12
Accepted
2003-11-12 11:08:19
Documents
7
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w91617e10vq.htm 10-Q 176397
3 EXHIBIT 10.1 w91617exv10w1.htm EX-10.1 17634
4 EXHIBIT 31.1 w91617exv31w1.htm EX-31.1 6832
5 EXHIBIT 31.2 w91617exv31w2.htm EX-31.2 6836
6 EXHIBIT 32.1 w91617exv32w1.htm EX-32.1 2684
7 EXHIBIT 32.2 w91617exv32w2.htm EX-32.2 2807
8 GRAPHIC w91617novavax.gif GRAPHIC 21707
  Complete submission text file 0000950133-03-003810.txt   237124
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 03991665
SIC: 2836 Biological Products, (No Diagnostic Substances)